Centrally situated in China’s capital, our Beijing office is a key location for domestic and foreign companies doing business in Greater China and the wider Asia-Pacific region. In collaboration with colleagues in offices around the world, our lawyers in Beijing leverage their market knowledge to advise clients involved in an array of sectors, including life sciences and healthcare, food and drugs, media and technology, consumer goods, financial services, and energy and infrastructure.
As China continues to grow in prominence as a world economic power, clients benefit from our Beijing team’s long history of representing companies in inbound and outbound transactions, including mergers and acquisitions, investment management issues, intellectual property deals, and general corporate and regulatory matters. Our lawyers also have experience handling Foreign Corrupt Practices Act investigations and training, government regulatory approvals, compliance, and investigations before various government agencies. Additionally, our team focuses on labor and employment matters.
Our lawyers advise corporate clients, financial institutions, and investors on debt, equity and special investments; stock exchange listings; and high-end corporate work, including public and private mergers, acquisitions, and takeovers; private equity; joint ventures; equity capital markets, including closed-end funds of hedge funds and other listings; and debt capital markets.
The Beijing team advises a wide range of public and private institutional and boutique investment management companies on all aspects of investment fund operations in Greater China and throughout Asia, North America, and Europe. We handle the full spectrum of investment funds and pooled investment vehicles, including retail mutual funds, hedge funds, private equity funds, and specialty funds. Our lawyers also advise on financial regulatory reforms in the United States and Europe, and the effect of the reforms on clients throughout the Asia-Pacific region.
We also assist clients in intellectual property creation and protection, including representing Chinese companies in litigation in the United States and in matters before the US Patent Trial and Appeal Board, as well as counsels on strategic intellectual property planning for global market entry and litigation when necessary.